99 studies found for:    Open Studies | "Anemia, Aplastic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment
Intervention: Drug: Eltrombopag
2 Recruiting Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Very Severe Aplastic Anemia;   Moderate Aplastic Anemia
Intervention: Drug: Eltrombopag
3 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath )
4 Recruiting Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Condition: Anemia, Aplastic
Intervention: Drug: Cyclophosphamide,Campath IH and TBI
5 Unknown  Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Procedure: Ex Vivo Immunotherapy;   Drug: Ex vivo immunotherapy
6 Unknown  Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
Condition: Anemia, Aplastic
Interventions: Drug: Sirolimus;   Drug: Cyclosporine
7 Recruiting A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: AMG531
8 Not yet recruiting Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
Conditions: Dyskeratosis Congenita;   Aplastic Anemia
Interventions: Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Stem Cell Transplant;   Drug: Anti-thymocyte globulin
9 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
10 Recruiting Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cy-ATG;   Drug: Flu-ATG
11 Recruiting Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia
Condition: Acquired Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: anti-thymocyte globulin;   Biological: filgrastim;   Radiation: Total body irradiation;   Procedure: CD3-depleted hematopoietic cell transplantation
12 Unknown  Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)
Condition: Aplastic Anemia
Intervention: Other: Cyclophosphosphamide, TBI
13 Recruiting Cord Blood Transplantation in Severe Aplastic Anemia
Conditions: Hereditary Diseases;   Acquired Aplastic Anemia;   Relapse;   Absence of an HLA Identical Donor
Intervention: Procedure: Cord Blood Transplantation
14 Not yet recruiting Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Condition: Aplastic Anemia
Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A);   Drug: Immunosupressive therapy (Cyclosporine A)
15 Recruiting Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome
Conditions: Myelodysplastic Syndrome (MDS);   Severe Aplastic Anemia (SAA)
Interventions: Other: Umbilical Cord Blood;   Other: Haploidentical Stem Cells;   Device: Miltenvi CliniMACs CD34 Reagent System
16 Unknown  Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
Condition: Aplastic Anemia and Other Marrow Failure Syndrome
Intervention: Other: Database
17 Recruiting Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Conditions: Severe Aplastic Anemia;   MDS (Myelodysplastic Syndrome)
Interventions: Device: Miltenyi CD34 Reagent System;   Other: Donor derived G-CSF mobilized PBC
18 Recruiting Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Anemia;   Thrombocytopenia
Interventions: Drug: Eltrombopag;   Drug: Horse Anti-Thymocyte Globulin (ATG);   Drug: Cyclosporine A (CSA)
19 Unknown  Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)
Condition: Aplastic Anemia
Intervention: Drug: Cyclophosphamide, Fludarabine, Thymoglobulin
20 Unknown  Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia.
Condition: Aplastic Anemia
Intervention: Biological: bone marrow derived mesenchymal stem cells

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years